Viruses and viral components can be potent inducers of alpha/beta interferons (IFN-␣
Many viral infections, including those with lymphocytic choriomeningitis virus (LCMV), induce high levels of alpha/beta interferons (IFN-␣/␤) early (3) . The importance of these cytokines for defense goes beyond their antiviral activities and includes many immunoregulatory functions (4, 5, 8, 16) . The factors are products of a multigene family including 1 IFN-␤ gene and at least 12 IFN-␣ genes. Each gene is regulated by its own distinct promoter, resulting in differential expression of subtypes. Viruses induce transcription of IFN-␣/␤ genes in cells by several different pathways. Some of these involve extracellular interactions between viral glycoproteins and cell surface receptors, whereas others rely on intracellular interactions between viral components and cytoplasmic receptors (6, 15) . IFN-␣/␤ can amplify their own expression in vitro through a positive feedback loop (14, 22) . This occurs in a two-step fashion, with the subtypes expressed early, IFN-␤ and IFN-␣4, signaling through the IFN-␣/␤ receptor (IFN-␣/␤R) and STAT1 to induce interferon regulatory factor 7 (IRF-7) expression that subsequently leads to induction of the non-IFN-␣4 (IFN-␣non4) subtypes upon interaction with virus (1, 14, (21) (22) (23) . Cells deficient for the IFN-␣/␤R or the STAT1 molecule are profoundly inhibited in their expression of IFN-␣/␤ in culture, especially the late subtypes. Furthermore, under particular challenge conditions, cells from mice lacking the gene for IFN-␤ are inhibited in overall expression of IFN-␣/␤ (9, 11) .
Our studies were undertaken to determine whether the bulk of the IFN-␣/␤ produced during in vivo LCMV infection is directly elicited by the virus or depends on the autocrine induction pathway and to identify the first LCMV-activated IFN-␣/␤ target gene. The kinetics and quantity of IFN-␣/␤ expression were examined after infection of wild-type (WT) mice and mice deficient for the IFN-␣/␤R (IFN-␣/␤R Ϫ/Ϫ ), the IFN-␥R (IFN-␥R Ϫ/Ϫ ), both IFN receptors (IFN-␣/␤␥R Ϫ/Ϫ ), or STAT1 (STAT1 Ϫ/Ϫ ). Our results demonstrate that the autocrine induction pathway is necessary for an optimal IFN-␣/␤ response in vivo and that a single first target gene cannot be detected. In the absence of a functional IFN-␣/␤R, however, an alternative pathway is activated, but with delayed kinetics. The alternative pathway is not dependent on the viral burden only and/or on STAT1 but is dependent on the IFN-␥R. Collectively, our data indicate that LCMV is a poor direct inducer of IFN-␣/␤ but that the host has mechanisms in place by which to promote cytokine production in response to infection with such an agent.
MATERIALS AND METHODS

Mice. The 129 IFN-␥R
Ϫ/Ϫ , IFN-␣/␤R Ϫ/Ϫ , or IFN-␣/␤␥R Ϫ/Ϫ mice were obtained from B&K Universal Limited (North Humberside, United Kingdom) or Joan Durbin, Ohio State University, Columbus (10) . STAT1 Ϫ/Ϫ C57BL/6 mice were from Joan Durbin (16) . All genetically deficient mice were bred under specific-pathogen-free conditions at Brown University. Age-matched WT C57BL/6 and 129/SvEv mice were purchased from Taconic Laboratory Animals and Services (Germantown, N.Y.). Mice used for experiments were 5 to 10 weeks old. Mice were handled in accordance with institutional guidelines for animal care and use.
Infections and preparation of biological materials. Mice were either uninfected or infected intraperitoneally at time zero with 2 ϫ 10 4 PFU of LCMV Armstrong clone E350 or the more aggressive and liver-tropic LCMV WE isolate (17, 19) . Mice were anesthetized and bled before sacrifice for organ harvesting. Sera, spleen homogenates, and peritoneal cells were prepared as previously described (8, 10, 16) . Viral titers in spleen homogenates were determined by plaque assays on Vero cells (18, 19) and expressed as PFU per gram.
RNA extraction, RT, and PCR. Total RNA was extracted from spleens and peritoneal cells, DNase treated (Ambion, Inc., Austin, Tex.), and analyzed by reverse transcription (RT)-PCR as previously described (20) . Briefly, 1 to 2 g of RNA was reverse transcribed into cDNA. For relative quantitative PCR, 5 l of cDNA was used as a template with primers specific for IFN-␣4, IFN-␣non4, IFN-␤, and IRF-7. Gene-specific primers were identified from publications (9, 14) and synthesized by Operon (Alameda, Calif.). As internal controls for random variations, 18S rRNA primers and competimers (Ambion Inc.) were used (20) . Amplifications were carried out in a programmable thermal cycler (PTC-200; MJ Research, Waltham, Mass.) with the following parameters: IFN-␣4 and IFN-␣non4, 32 cycles and an annealing temperature of 55°C; IFN-␤, 36 cycles and an annealing temperature of 56°C; IRF-7, 30 cycles and an annealing temperature of 57°C. Southern blot hybridization with an internal oligonucleotide psoralen-biotin-labeled probe (Ambion, Inc.) was used to verify the specificity of IFN-␣4 and IFN-␣non4 RT-PCR products. The IFN-␣non4 probe detected only IFN-␣non4 PCR products and not IFN-␣4 PCR products and vice versa.
Measurement of IFN-␣/␤ levels. IFN-␣/␤ bioactivity in sera and spleen homogenates was detected by a biological assay for protection against vesicular stomatitis virus (12). The dilution mediating 50% protection was defined as containing 1 U of IFN per ml. Specificity was determined by neutralization with rabbit anti-mouse IFN-␣/␤ (Lee Biomolecular Research Laboratories, San Diego, Calif.). High levels of IFN-␥ did not interfere with the assay. 
RESULTS
Importance of IFN receptors for induction of IFN-␣/␤ cytokines during in vivo infection.
To examine the in vivo importance of the autocrine induction pathway, WT, IFN-␣/ ␤R Ϫ/Ϫ , IFN-␥R Ϫ/Ϫ , or IFN-␣/␤␥R Ϫ/Ϫ mice were infected with LCMV Armstrong or LCMV WE. The kinetics and magnitudes of the IFN-␣/␤ responses were measured by biological assays. In WT mice, strong induction of bioactive IFN-␣/␤ expression was detected in both sera (Fig. 1A ) and spleen homogenates (Fig. 1B ) at 24 and 48 h after infection with LCMV Armstrong. The IFN-␥R Ϫ/Ϫ mice showed kinetics similar to those of the WT mice (data not shown). In contrast, IFN-␣/␤R Ϫ/Ϫ mice had either no bioactive IFN-␣/␤ or barely detectable levels of bioactive IFN-␣/␤ at 24 h but recovered at 48 h after infection, when levels of IFN-␣/␤ were normal in the serum (Fig. 1A) and increasing in the spleen (Fig. 1B) . However, in IFN-␣/␤␥R Ϫ/Ϫ mice, profoundly reduced IFN-␣/␤ levels were detected at both 24 and 48 h ( Fig. 1A and B) . Similar trends were observed after infection with LCMV WE, a more aggressive virus replicating to higher titers, but recovery in IFN-␣/␤R Ϫ/Ϫ mice was less dramatic ( (Fig. 1B) and viral burdens and IFN-␣/␤ production did not correlate. To localize virus-infected cells and IFN-producing cells, spleen sections from uninfected mice and mice infected with LCMV for 48 h were examined by immunohistochemical analysis. Quantitatively, the IFN-␣/␤ staining reflected the bioassay results (Fig. 1B) . No IFN-␣/␤ protein or LCMV antigen could be detected in uninfected animals ( Fig. 2A and E) . At 48 h after infection, IFN-␣/␤ proteins were abundant in WT mice, with staining localized mainly in red pulp (Fig. 2B) . In IFN-␣/␤R Ϫ/Ϫ mice, levels of IFN-␣/␤ expression were reduced but the localization pattern was the same as that in WT mice (Fig. 2C) . In contrast, staining for IFN-␣/␤ protein was very restricted in IFN-␣/ ␤␥R Ϫ/Ϫ mice (Fig. 2D) . LCMV antigen was detected in WT mice at 48 h but only as a few localized clusters in red pulp (Fig. 2F) . Consistent with the viral titer data, LCMV antigen was much more abundant in the tissues from both receptordeficient mice. Here, the infected cells localized mainly in the marginal zone and the proximal white pulp (Fig. 2G and H) . (Fig. 3A) . However, at 48 h, strong expression of mRNAs for the three different IFN-␣/␤ subtypes was observed in WT, IFN-␥R Ϫ/Ϫ , and IFN-␣/␤R Ϫ/Ϫ mice whereas only weak expression was detected in IFN-␣/␤␥R Ϫ/Ϫ mice (Fig. 3A) . To determine whether LCMV could directly induce early IFN-␣/␤ expression independently of the amplification pathway, differential expression of the subtypes was examined at earlier times after infection of WT and IFN-␣/ ␤R Ϫ/Ϫ mice. As infections were done intraperitoneally, RNA was extracted from both spleen and peritoneal cells. At 12 h after infection, no IFN-␣/␤ message was detectable in spleen or peritoneal cells (Fig. 3B) . At 16 h, weak expression of IFN-␣non4 was sometimes detected in the spleens of WT mice. Only at 20 h after infection was strong and consistent expression of IFN-␣/␤ mRNA observed. Even though the spleen expressed mainly IFN-␣non4 and IFN-␣4 at this time point, all three IFN subtypes were detected in the peritoneum (Fig. 3B) . No initial expression of IFN-␣/␤ was detected in IFN␣/␤R Ϫ/Ϫ mice at 12 to 20 h after infection. These data demonstrate that all three IFN-␣/␤ subtypes are expressed in WT, IFN-␥R Ϫ/Ϫ , and IFN-␣/␤R Ϫ/Ϫ mice. They also suggest that although they are delayed in IFN-␣/␤R Ϫ/Ϫ mice, all three subtypes are expressed coincidentally. Thus, there is no detectable single direct IFN gene target for LCMV.
IFN receptor requirements for expression of IRF-7. As IRF-7 can be a transcription factor for the autocrine amplification loop, IRF-7 expression in the spleens of mice was analyzed by RT-PCR. Weak constitutive expression was observed in samples from WT and especially IFN-␥R Ϫ/Ϫ mice. In these mice, strong IRF-7 expression was induced already at 16 h after infection with LCMV and continued through 72 h postinfection (Fig. 4) . In the IFN-␣/␤R Ϫ/Ϫ mice, IRF-7 expression was observed but not until 72 h after infection. It was, however, observed at the earlier 48-h time point in samples prepared from other compartments (data not shown). In IFN-␣/␤␥R Ϫ/Ϫ mice after 24 h of infection, although at a low level (Fig. 5C) . However, at 48 h after infection, clear expression was observed in both types of mice. Thus, the early induction pathway for IFN-␣/␤ is STAT1 dependent but the alternative delayed-induction pathway is not.
DISCUSSION
These studies demonstrate that production of IFN-␣/␤ early during LCMV infection of mice is dependent upon the IFN-␣/␤R and the STAT1 molecule. Although this autocrine induction pathway is of major importance early, alternative mechanisms, independent of the IFN-␣/␤R and STAT1 but dependent on a functional IFN-␥R, can be activated. As the amounts of IFN-␣/␤ produced do not correlate with viral titers Taken together, the results show that the host has evolved a variety of mechanisms by which to facilitate IFN-␣/␤ induction in response to infections with viral agents with a poor ability to directly activate expression of the factors. To our knowledge, this is the first report directly demonstrating function of the IFN-␣/␤ amplification pathway in vivo. The results are consistent with and extend earlier in vitro studies demonstrating that IFN-␣/␤ can promote its own expression through induction of transcription factors not expressed constitutively, i.e., IRF-7 (14, 21, 22) . In contrast to the in vitro experiments, however, we had two surprising in vivo observations. First, the studies showed that without the assistance of endogenous amplification pathways, LCMV is a poor direct inducer of IFN-␣/␤ expression. Thus, this virus is different from the potent IFN-␣/␤-inducing agents New Castle disease virus and Sendai virus, which appear to directly activate at least a subset of IFN-␣/␤ genes. As early IFN-␣/␤ expression is dependent on activation of the constitutively expressed transcription factor IRF-3 (13, 23) , the poor ability of LCMV to induce IFN-␣/␤ may result from ineffective activation of IRF-3. The potent induction of IFN-␣/␤ in response to LCMV infection in WT mice may be a result of low-level background endogenous IFN-␣/␤ production and signaling to induce the alternative transcription factor activating expression of a broader range of IFN-␣/␤ gene targets, IRF-7, and activation of IRF-7 by LCMV. As other members of the IRF family promoting IFN-␣/␤ expression may also be endogenously regulated through endogenous IFN functions (1, 2), other possibilities exist. However, in agreement with at least one other report showing endogenous IRF-7 expression in mouse embryo fibroblasts (21), we observed low-level expression of IRF-7 in the spleens (Fig. 4) and livers (data not shown) of uninfected WT and IFN-␥R Ϫ/Ϫ mice. This IRF-7 expression was not detectable in IFN-␣/␤R Ϫ/Ϫ or IFN-␣/␤␥R Ϫ/Ϫ mice (Fig. 4) . Thus, our results indicate that amplification pathways for IFN-␣/␤ expression are in place not only to facilitate production of high levels of the factors but also to make it possible, under certain viral infection conditions, to induce these cytokines at all. Background induction of IRF-7 may be one such mechanism.
The second surprising observation from our studies is that an alternative delayed pathway for (Fig. 4) can be detected before IRF-7 expression in this compartment, alternative IRF-7-independent induction pathways may exist. IRF-5 has been implicated in the induction of genes for IFN-␣ (2), but other, unidentified, factors may also contribute. However, IRF-7 induction could be detected at times overlapping with rescued IFN-␣/␤ production in other compartments (data not shown). Therefore, the levels of expression may have simply been too low to detect in the spleen.
The compartmental differences observed between the serum and spleen with respect to the late alternative induction of IFN-␣/␤ in mice deficient for the IFN-␣/␤R (Fig. 1) or STAT1 (Fig. 5) are interesting. The IFN-␣/␤ levels were most normalized in the serum after 48 h of infection. These results suggest that IFN-␣/␤ in serum originates from compartments other than, or in addition to, the spleen and that the alternative induction pathway is not fully functional in the spleen. Other work in our laboratory has found other compartmental differences in cytokine production and function (19, 20) .
Our immunohistochemical analyses of spleens from WT mice demonstrate that IFN-␣/␤ is expressed by cells that fail to produce detectable levels of LCMV antigen (Fig. 2) . It is not clear whether this is indicative of populations challenged with LCMV but blocked for LCMV replication and antigen expression as a result of IFN-␣/␤ antiviral effects or of virus-inde- Taken together, these results demonstrate the plasticity available in vivo for IFN-␣/␤ induction during viral infections. Given the important antiviral and immunoregulatory functions activated by these factors, the physiological role of the various induction pathways could be to ensure a protective IFN-␣/␤ response even during infections with viruses that are poor IFN inducers. The alternative induction pathway might secure highlevel expression of IFN-␣/␤ under conditions in which the cell is short of STAT1 or others factors needed for the IFN-␣/␤R-dependent induction pathway. Given the complexity of the genes for IFN-␣/␤ and their promoters, a variety of mechanisms are likely to be in place to access these cytokines in vivo.
